Antwi-Amoabeng, D.; Sathappan, S.; Beutler, B.D.; Ulanja, M.B.; Awad, M.; Gullapalli, N.; Duncan, P.; Gbadebo, T.D.
Association between Empagliflozin Use and Electrocardiographic Changes. Clin. Pract. 2022, 12, 557-564.
https://doi.org/10.3390/clinpract12040059
AMA Style
Antwi-Amoabeng D, Sathappan S, Beutler BD, Ulanja MB, Awad M, Gullapalli N, Duncan P, Gbadebo TD.
Association between Empagliflozin Use and Electrocardiographic Changes. Clinics and Practice. 2022; 12(4):557-564.
https://doi.org/10.3390/clinpract12040059
Chicago/Turabian Style
Antwi-Amoabeng, Daniel, Sunil Sathappan, Bryce D. Beutler, Mark B. Ulanja, Munadel Awad, Nageshwara Gullapalli, Phillip Duncan, and T. David Gbadebo.
2022. "Association between Empagliflozin Use and Electrocardiographic Changes" Clinics and Practice 12, no. 4: 557-564.
https://doi.org/10.3390/clinpract12040059
APA Style
Antwi-Amoabeng, D., Sathappan, S., Beutler, B. D., Ulanja, M. B., Awad, M., Gullapalli, N., Duncan, P., & Gbadebo, T. D.
(2022). Association between Empagliflozin Use and Electrocardiographic Changes. Clinics and Practice, 12(4), 557-564.
https://doi.org/10.3390/clinpract12040059
